11 Best Breakout Stocks to Buy According to Analysts

Page 9 of 9

1. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)

Stock Upside Potential as of May 2: 138.02%

Number of Hedge Fund Holders: 20

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is a clinical-stage biotechnology company focused on developing small-molecule drugs for viral infections and immunological diseases. Its product pipeline includes EDP-514 for the treatment of hepatitis B virus or HBV; EDP-938 and EDP-323 for the treatment of respiratory syncytial virus; and EDP-235 for the treatment of human coronaviruses and Glecaprevir.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is up by about 8% for the year, emerging as one of the best breakout stocks to buy, according to analysts, as the overall market remains under pressure. The rally comes at the backdrop of Enanta Pharmaceuticals progress in developing RSV compounds and expanding its immunology portfolio. It has also delivered positive results from its pediatric RSV study.

In addition, the clinical-stage company is advancing and expanding its immunology portfolio while targeting Type 2 immune diseases. Revenue for its fiscal first quarter ended December 31, 2024, totaled $17 million as net loss shrunk to $22.3 million from $33.4 million in the same quarter the previous year.

While we acknowledge the potential of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ENTA but that trades at less than 5 times its earnings check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9